查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861835

携带式诊断影像设备市场按产品类型、便携性类型、应用、最终用户、技术和价格分布－2025-2032年全球预测

Portable Diagnostic Imaging Market by Product Type, Portability Type, Application, End User, Technology, Price Range - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，可携式诊断成像市场规模将达到 476.9 亿美元，复合年增长率为 8.08%。

关键市场统计数据
基准年 2024 255.9亿美元
预计年份：2025年 277.1亿美元
预测年份 2032 476.9亿美元
复合年增长率 (%) 8.08%

权威地介绍了由小型化、互联互通和临床工作流程变革驱动的诊断影像快速去中心化进程。

携带式诊断影像设备已从医院影像实验室的专用设备发展成为种类繁多的设备，使患者能够更便捷地获得诊断服务。这项转变得益于技术小型化、数位讯号处理技术的进步以及无线连接技术的日趋成熟，这些技术使得设备能够在临床、现场和家庭环境中可靠运作。因此，医疗服务路径正变得更加分散化，诊断服务不再集中于中心化，而是在需要的地方提供。

影像技术与云端运算和边缘分析的整合正在重塑临床工作流程，并加速分流决策。临床医生正在利用携带式CT、各种MRI设备、超音波、分子影像和小型X光系统来收集可操作的信息，而这些信息以前需要患者转运或延误就诊时间。从急救响应到家庭慢性病监测，这些技术正在扩大诊断服务的覆盖范围，并支持更及时的干预措施。同时，设计重点正在转向符合人体工学的外形、更高的能源效率和更简化的使用者介面，从而最大限度地减少培训负担，并简化与非传统医疗环境的整合。

在产品开发週期中，监管和互通性标准的重要性日益凸显，相关人员对资料安全和临床疗效的期望也是如此。因此，产品的普及不仅取决于其效能，还取决于供应商能否提供强有力的临床证据、可靠的生命週期支援和安全的资料管理。本文透过分析产业现状、影响近期竞争优势的因素以及决定哪些携带式诊断成像解决方案能够获得广泛且持续应用的关键营运考量，为后续分析建立了框架。

小型化、软体主导的生态系统、模组化互通性和供应链韧性如何共同重塑携带式诊断成像格局

携带式诊断影像领域正经历一场深刻的技术主导变革，这场变革正在改变临床实务、采购模式和病患诊疗路径。感测器小型化和低场磁振造影架构的技术进步，使得设备更加轻巧、节能，也更容易在受限环境中部署。同时，超音波系统也正从大型主机发展成为具备极其先进影像处理能力的携带式和智慧型手机连接设备。人工智慧辅助影像分析和自动化测量工具的引入，降低了专业技能的门槛，并将潜在用户群扩展到诊断成像专家之外。

连结性和软体定义功能也正在创造新的价值层面。云端对应平臺和边缘运算支援安全影像传输、远端会诊和持续软体改进，无需更换硬件，从而延长设备使用寿命并实现基于订阅的软体盈利模式。同时，模组化和平台化方法促进了不同模式之间的互通性，使医疗机构更容易将携带式设备整合到现有的临床资讯系统中。因此，采购决策越来越受到设备生态系统相容性和长期软体蓝图的影响，而不仅仅是硬体特性。

随着急诊、门诊中心和居家医疗机构采用照护现场技术加快诊断速度，临床工作流程模式正在转变。部分地区的健保报销政策调整以及旨在缩短患者周转时间的营运奖励，都为这一转变提供了支持。此外，近期全球范围内的动盪使得供应链韧性和零件采购的地域多元化成为策略重点，迫使许多製造商重新评估其筹资策略，并增加关键零件的在地采购。这些变革性变化正在重新定义携带式诊断影像设备的竞争优势，并影响产品蓝图、商业模式和监管应对措施。

评估美国关税政策在2025年前对诊断影像产业供应链策略、采购权衡和商业性差异化的影响

美国关税的实施和调整（直至2025年）对携带式诊断成像设备供应链中的製造商、经销商和医疗采购商产生了切实的影响。影响关键零件、原材料和成品的关税衝击了成本结构，促使企业重新评估筹资策略，并评估区域製造地和售后支援地点的财务可行性。许多企业正在采取措施降低惩罚性关税和运输延误的风险，例如供应商多元化、增加库存缓衝或加快组装和测试流程的本地化。

这些变化不仅限于成本。关税也会与监管合规和物流复杂性相互作用，影响产品上市时间和定价透明度。依赖跨境采购的供应商可能面临更长的前置作业时间和更复杂的保固管理。因此，采购团队和临床负责人必须仔细权衡短期采购成本节约与长期可维护性、备件供应以及全生命週期总拥有成本之间的利弊。与此同时，各公司正在重新思考其分销模式以减轻关税负担。例如，这些模式包括建立区域分销中心，以及与当地委託製造合作，在关税优惠地区进行最终组装。

此外，日益严峻的关税环境正在加速非价格属性（例如临床证据、软体服务和综合培训项目）的竞争差异化。随着成本压力波及整个价值链，那些能够提供强大的远端支援、可预测的维护计划以及清晰的云端和人工智慧服务升级路径的公司，更有可能在价格波动的情况下保持客户忠诚度。最后，包括供应链安全和区域产业政策在内的公共采购政策，正日益影响供应商的选择，凸显了采购和营运规划透明度和韧性的必要性。

将产品类型、可携性、临床应用、最终用户、技术堆迭和价格分布因素纳入策略决策流程，进行全面的市场区隔分析。

携带式诊断成像市场的最佳理解方式是透过层级细分，这种细分方式揭示了临床需求、产品创新和商业性机会的交汇点。产品类型差异涵盖了电脑断层扫描 (CT) 的各种类型、分子成像、磁振造影 (MRI) 配置、超音波格式和 X 光解决方案。在此框架下，CT 分为锥状射束和螺旋两种配置，每种配置都针对不同的操作限制和空间权衡。分子影像分为正子断层扫描 (PET) 和单光子发射电脑断层扫描 (SPECT)，每种类型都有不同的示踪剂输送方法和临床应用场景。磁振造影技术根据磁场强度和设计用途进一步细分，包括用于传统成像的高场系统、优先考虑性能和部署灵活性的中场系统以及优先考虑便携性的超低场创新技术。

超音波在便携性方面呈现出多样性，从传统的二维仪器到适用于血管和心臟病学应用的三维和多普勒平台，应有尽有。手持式设备包括专用设备和可连接智慧型手机的型号，而无线配置则包括支援蓝牙和Wi-Fi的型号，每种配置在连接性、安全性和整合性方面都有不同的要求。 X光设备也同样呈现两极化的趋势，电脑放射成像和全数数位放射线方法在影像处理工作流程和现场储存要求方面存在差异。便携性进一步将市场细分为手持式、笔记型电脑式和推车式解决方案。手持式设备分为专用硬体和基于智慧型手机的系统，而笔记型电脑式系统则可以采用标准尺寸或平板电脑的形式。推车式平台包括交流电源供电和电池供电两种版本，每种版本在行动性和部署场景方面都有相应的限制。

应用细分揭示了可携式诊断成像技术能够发挥最大价值的临床场景。紧急应用场景涵盖加护治疗和创伤工作流程，在这些场景中，快速诊断至关重要；而居家医疗则支援慢性病监测和老年护理。军事部署必须应对战区和野战医院的限制，而即时诊断应用则涵盖腹部、心臟、肌肉骨骼、产科和血管等领域。兽医应用分为大型动物和小型动物两种模式，每种模式对设备的尺寸和耐用性要求各不相同。最终用户细分包括诊所、诊断中心、居家照护机构、医院和门诊中心。在这些类别中，所有权模式和机构类型（政府诊所与私人诊所、影像中心与实验室、私人居家照护机构与公立家庭护理机构、综合医院与专科医院、门诊手术中心与门诊復健中心）会影响采购週期和支持预期。

技术和价格分布细分也发挥着重要作用。类比/数位的区分沿着工作流程现代化的方向将市场细分，基于胶片的类比方法逐渐被云端和本地部署的数位基础设施所取代，从而改变了影像存取和存檔策略。价格分布——从经济实惠的低端设备，到中阶入门级和标准型号，再到高端和超高端产品——驱动着不同的价值提案。高端解决方案强调先进的成像功能和全面的服务合同，而低端设备则优先考虑价格实惠和基本的诊断功能。总而言之，这些细分观点为供应商和买家提供了详细的路线图，帮助他们评估产品开发、临床检验和商业性投资的重点方向，以满足客户的细微需求。

影响携带式诊断影像设备普及的区域采用模式和基础设施（美洲、欧洲、中东和非洲、亚太地区）

区域趋势对携带式诊断成像技术的应用模式、监管要求和商业策略起着决定性作用。在美洲，人们特别重视与现有医院网路的整合，急诊和门诊环境中照护现场的快速普及，以及奖励能够显着提高诊疗效率和临床疗效的医保报销机制。该地区的采购週期往往优先考虑能够与电子健康记录 (EHR) 和企业级影像平台无缝整合的设备，而服务网路和应对力在供应商选择中起着关键作用。

欧洲、中东和非洲地区（EMEA）呈现多元化的格局，法规结构、报销奖励和融资环境差异显着。在欧洲部分地区，集中采购和严格的临床管治更倾向于选择拥有可靠证据包和良好互通性记录的解决方案。同时，中东市场通常优先考虑快速部署能力和本地支持，而撒哈拉以南非洲地区则特别注重耐用性、能源效率和简化的维护流程。对于能够提供适应性强的服务模式和耐用设计，以应对全部区域基础设施多样性的供应商而言，存在着巨大的机会。

亚太地区正经历着由都市化、基层医疗能力提升以及医疗基础设施的大量投资所驱动的强劲需求。该地区多个国家正在大力推动远端医疗和居家医疗倡议，这些计划依赖携带式影像设备进行远距离诊断和慢性病管理。此外，不断壮大的国内製造业基础和日益完善的监管体係也在影响采购决策，买家越来越倾向于选择扩充性、经济高效且能在不同地区得到支持的设备。这些区域性特征凸显了根据当地临床实务、报销环境和基础设施实际情况客製化产品功能、服务内容和商业性策略的重要性。

竞争格局趋势：传统製造实力、硬体专用创新与云端/人工智慧伙伴关係的整合决定市场领导地位

携带式诊断影像设备的竞争格局呈现出多元化的特点，既有成熟的原始设备製造商 (OEM)，也有专注于特定领域的创新企业，以及利用软体和人工智慧来提升诊断价值的灵活Start-Ups。现有企业通常凭藉产品系列、全球服务网络以及完善的监管管道（便于医疗系统进行大规模采购）展开竞争。为了维护机构买家的信任，这些现有企业通常会在上市后监测、临床研究和全面的培训计画方面投入大量资金。

同时，专注于特定领域的专业公司和新参与企业正透过创新推动市场转型，例如手持式超音波设备、低场磁振造影系统和紧凑型CT设计。它们的优势在于快速的产品改进、针对特定应用情境的临床检验，以及以软体订阅和管理服务为核心的经营模式。硬体开发商与软体/云端服务供应商之间的合作日益普遍，使设备能够提供先进的影像处理、决策支援和远端会诊功能。这种合作模式透过消除影像解读瓶颈和实现远端专家协助，降低了临床应用门槛。

随着企业寻求将硬体技术与先进的软体功能和本地分销经验相结合，併购、策略联盟和授权授权已成为反覆出现的主题。对于优先考虑运作和本地维护的分散式医疗环境中的买家而言，供应链整合和可维护性仍然是重要的竞争优势。影像重建演算法、低功耗硬体设计和人工智慧诊断支援工具的智慧财产权也是关键的竞争优势所在，能够保护这些资产并将其商业化的公司将更有利于获取长期价值。整体而言，竞争格局往往更有利于那些能够平衡产品可靠性、软体驱动的临床价值和强大的支援基础设施的公司。

为确保携带式诊断影像设备的临床应用、稳定供应和持续收入来源，设备製造商和医疗保健领导者可采取切实可行的策略重点。

产业领导者应优先考虑整合硬体可靠性、软体临床效用和强大的售后支援等综合价值提案。积极投资于临床证据产生和独立检验研究将加速医院采购委员会和认证机构对产品的采纳。同时，允许软体和连接升级的模组化产品架构可延长设备生命週期，并透过託管服务和订阅模式创造持续收入。

在营运层面，应考虑供应链多元化，并考虑区域性最终组装和委託製造，以降低关税和物流风险。建立远距离诊断、预测性维护和备件预测机制，可以减少停机时间，增强客户信任，尤其是在分散的医疗环境中。商业策略应强调与远端医疗平台、电子病历供应商和区域服务机构的合作，以确保无缝整合并降低最终用户的使用障碍。定价和报销策略应与已证实的临床和营运效益一致。试验基于价值的合约模式有助于充分利用照护现场的效率提升。

最后，对培训计画、直觉的使用者介面和临床医生决策支援的投资将扩大使用者群体，并减少对专业操作人员的依赖。透过结合临床检验、软体灵活性、供应链韧性和卓越的服务，业界领导者可以将当前的衝击转化为可持续的竞争优势，并推动其在医疗保健领域内外广泛应用。

结合关键相关人员访谈、技术文件审查和三角验证检验的稳健混合调查方法，确保了研究结果的可操作性和检验。

支持这些发现的研究采用了混合方法，结合一手和二手研究，以确保分析的严谨性。一手研究包括对急诊医学、放射学、居家医疗和军事医疗服务领域的临床终端用户、采购负责人和技术专家进行结构化访谈，并辅以与医疗设备製造商的产品经理和供应链主管的讨论。这些讨论重点关注各种便携格式和临床应用的实际性能、可维护性问题以及推广应用障碍。

二次研究包括对同行评审的临床研究、监管申报文件、产品技术规范以及记录设备性能特征、安全性概况和互通性能力的行业白皮书进行系统性回顾。在有权威监管标准和指南的情况下，参考这些标准和指南来理解合规要求并评估临床实施所需的证据。物流和贸易出版物中的数据用于供应链模式和关税相关影响分析，而技术趋势报告则有助于了解小型化、互联互通和基于人工智慧的图像分析的最新进展。

分析方法包括从细分角度进行比较特征映射、情境分析以评估供应炼和关税方面的突发情况，以及将关键发现与已记录的产品绩效进行交叉检验。此调查方法的局限性包括不同器械类别的已发表临床证据存在差异，以及采购和报销政策存在区域差异。为弥补这些局限性，我们进行了多项独立的相关人员检验，并进行了敏感性检验，以确保结论的稳健性。最终形成的框架将经验观察与策略解读相结合，为製造商、供应商和投资者提供决策支援。

结论：整合技术进步、临床证据和营运韧性是携带式诊断影像持续成功的决定因素

携带式诊断影像设备正处于转折点，技术进步、医疗服务模式的转变以及商业性创新正在融合，从而将诊断范​​围扩展到传统环境之外。拥有可靠硬体、灵活的软体生态系统、强大的售后支援和明确的临床证据的设备最能满足日益增长的现场即时诊断需求。对于市场参与企业而言，至关重要的是平衡创新速度和卓越运营，新产品的推出必须伴随相应的服务模式和整合方案，以降低用户采用门槛。

监管、关税和供应链方面的压力要求企业具备策略远见，包括加强筹资策略、投资本地支援体係以及与买家就生命週期成本进行透明对话。临床领导者和采购团队应优先考虑那些具备互通性、安全性和对临床工作流程有显着影响的设备。最终，最成功的解决方案将是那些能够在速度和便利性显着改善患者预后和系统效率的环境中，提供可靠、易用的诊断影像方案。

透过将产品开发与已证实的临床需求相结合，并建立稳健的商业和营运基础设施，相关人员可以加速携带式诊断影像技术的普及应用，并将其可持续地整合到多样化的诊疗路径中。这一领域的蓬勃发展为那些愿意投资于循证实践、服务性和平台主导的价值创造的企业提供了极具吸引力的机会。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到携带式诊断成像设备中，用于即时分析
  • 具备远端医疗连接功能的携带式超音波诊断设备的兴起（用于远端医疗和诊断）
  • 开发一种无线、电池供电、可携式X 光系统，用于野战医院的现场放射检查。
  • 推出用于急诊和照护现场诊断的小型化CT扫描仪
  • 扩展云端基础的影像储存和协作平台，以实现携带式影像工作流程
  • 监管改革旨在加速创新携带式诊断影像设备的核准流程

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章携带式诊断影像设备市场（按产品类型划分）

  • CT
    • 锥状射束CT
    • 螺旋CT
  • 分子影像
    • PET
    • SPECT
  • MRI
    • 高磁场
    • 中等磁场
    • 超低磁场
  • 超音波
    • 2D
    • 3D
    • 多普勒
    • 手持式
      • 专用设备
      • 基于智慧型手机
    • 无线的
      • 蓝牙功能
      • 具备 Wi-Fi 功能
  • X射线
    • 电脑放射成像
    • 数位放射线

第九章携带式诊断影像设备市场（按便携性类型划分）

  • 手持式
    • 专用设备
    • 基于智慧型手机
  • 笔记型电脑底座
    • 标准集成
    • 平板电脑集成
  • 手推车底座
    • 交流电源
    • 电池供电

第十章携带式诊断影像设备市场（按应用划分）

  • 紧急状况
    • 加护治疗
    • 创伤
  • 居家医疗
    • 慢性病监测
    • 老年护理
  • 军队
    • 战斗区
    • 野战医院
  • 照护现场
    • 腹部
    • 心臟病学
    • 肌肉骨骼系统
    • 产科
    • 血管
  • 兽医学
    • 大型动物
    • 小动物

第十一章携带式诊断影像设备市场（以最终用户划分）

  • 诊所
    • 政府
    • 私人的
  • 诊断中心
    • 影像中心
    • 考场
  • 居家医疗保健服务提供者
    • 私人的
    • 公共
  • 医院
    • 一般的
    • 专科医院
  • 门诊治疗中心
    • 门诊手术
    • 復原

第十二章携带式诊断影像设备市场（依技术划分）

  • 模拟
    • 薄膜基
  • 数位的
    • 云端
    • 本地部署

第十三章携带式诊断影像设备市场（依价格分布）

  • 高阶
    • 优质的
    • 超高阶
  • 低阶
    • 经济
  • 中檔
    • 入门级
    • 标准

第十四章携带式诊断影像设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章携带式诊断影像设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国携带式诊断影像设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • GE Healthcare
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Samsung Medison Co., Ltd.
    • Hitachi, Ltd.
    • Esaote SpA
    • Shimadzu Corporation
Product Code: MRR-2A0283E25686

The Portable Diagnostic Imaging Market is projected to grow by USD 47.69 billion at a CAGR of 8.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 25.59 billion
Estimated Year [2025] USD 27.71 billion
Forecast Year [2032] USD 47.69 billion
CAGR (%) 8.08%

An authoritative introduction to the rapid decentralization of diagnostic imaging driven by miniaturization, connectivity, and clinical workflow transformation

Portable diagnostic imaging has evolved from specialist equipment tethered to hospital imaging suites into a diverse ecosystem of devices that push diagnostic capacity closer to the patient. This transition is driven by technological miniaturization, advances in digital signal processing, and the maturation of wireless connectivity, which together enable devices to operate reliably in clinical, field, and domiciliary settings. As a result, care pathways are becoming more decentralized, with diagnostics delivered at the point of need rather than being concentrated in central facilities.

The convergence of imaging modalities with cloud computing and edge analytics is reshaping clinical workflows and enabling faster triage decisions. Clinicians are using portable CT, MRI variants, ultrasound, molecular imaging, and compact X-ray systems to gather actionable information that previously required patient transport and scheduling delays. From emergency response to home-based chronic disease monitoring, these technologies expand the reach of diagnostic services and support timelier interventions. In parallel, design priorities have shifted toward ergonomic form factors, power efficiency, and simplified user interfaces to minimize training burdens and streamline integration into non-traditional care settings.

Regulatory scrutiny and interoperability standards are increasingly central to product development cycles, and stakeholder expectations for data security and clinical validation are rising. Adoption is therefore mediated not only by device performance, but also by the extent to which vendors can demonstrate robust clinical evidence, reliable lifecycle support, and secure data management. This introduction frames the subsequent analysis by highlighting where the sector is now, the forces shaping near-term competitive advantage, and the operational considerations that will decide which portable imaging solutions achieve broad, sustained adoption.

How miniaturization, software-driven ecosystems, modular interoperability, and supply chain resilience are collectively reshaping portable diagnostic imaging dynamics

The landscape of portable diagnostic imaging is undergoing profound, technology-led shifts that are transforming clinical practice, procurement models, and patient pathways. Technological advances in sensor miniaturization and low-field MRI architectures are enabling devices that are lighter, more energy-efficient, and easier to deploy in constrained environments. Simultaneously, ultrasound systems have progressed from bulky consoles to handheld instruments and smartphone-integrated devices that offer surprisingly sophisticated imaging capabilities, supported by AI-assisted interpretation and automated measurement tools. These innovations lower the barrier to skilled operation and expand the pool of potential users beyond imaging specialists.

Connectivity and software-defined functionality are also creating new value layers. Cloud-enabled platforms and edge computing allow for secure image transfer, remote consultation, and continuous software improvement without hardware replacement. This increases device lifespan and enables subscription-style software monetization. At the same time, modularity and platform approaches are promoting interoperability across modalities, making it simpler for institutions to integrate portable units into existing clinical information systems. Consequently, purchasing decisions are increasingly influenced by a device's ecosystem compatibility and long-term software roadmap rather than by hardware features alone.

Clinical workflow paradigms are shifting as emergency departments, outpatient centers, and home care providers integrate point-of-care imaging to expedite diagnosis. This evolution is supported by reimbursement adjustments in some jurisdictions and by operational incentives to reduce patient throughput times. Finally, supply chain resilience and geographic diversification of component sourcing have become strategic priorities following recent global disruptions, prompting many manufacturers to rethink sourcing strategies and to increase localization of critical components. Together, these transformative shifts are redefining competitive advantage in portable diagnostic imaging and setting the agenda for product roadmaps, commercial models, and regulatory engagement.

Assessing how evolving United States tariff measures through 2025 have reshaped supply chain strategy, procurement trade-offs, and commercial differentiation in imaging

The imposition and evolution of tariffs by the United States through 2025 have had tangible implications for manufacturers, distributors, and healthcare buyers within the portable diagnostic imaging supply chain. Tariffs affecting key components, raw materials, and assembled devices influence cost structures, prompting firms to reassess sourcing strategies and to evaluate the financial viability of regional manufacturing and aftermarket support hubs. In many cases, companies have responded by diversifying supplier bases, increasing inventory buffers, or accelerating localization of assembly and testing processes to mitigate exposure to punitive duties and transit delays.

These shifts are not limited to cost considerations. Tariffs interact with regulatory compliance and logistics complexity to shape go-to-market timing and pricing transparency. Providers that rely on cross-border procurement may encounter longer lead times and more complex warranty administration. Consequently, procurement teams and clinical leaders must weigh the trade-offs between short-term acquisition cost savings and longer-term serviceability, spare-part availability, and lifecycle total cost of ownership. In parallel, firms are revisiting distribution models to reduce tariff drag, for example by establishing regional distribution nodes or by partnering with local contract manufacturers to perform final assembly in tariff-friendly jurisdictions.

Moreover, the tariff environment has intensified competitive differentiation around non-price attributes such as clinical evidence, software services, and integrated training programs. As cost pressures ripple through the value chain, companies that offer robust remote support, predictable maintenance schedules, and clear upgrade paths for cloud and AI-enabled services tend to retain customer trust despite price volatility. Finally, public procurement policies that factor in supply chain security and regional industrial policy are increasingly influencing vendor selection, underscoring the need for transparency and resilience in sourcing and operational planning.

Comprehensive segmentation insights connecting product types, portability formats, clinical applications, end users, technology stacks, and price tiers to strategic decision pathways

The portable diagnostic imaging market is best understood through layered segmentation that reveals where clinical demand, product innovation, and commercial opportunity intersect. Product-type differentiation spans computed tomography variants, molecular imaging, magnetic resonance configurations, ultrasound formats, and X-ray solutions. Within this framework, CT diverges into cone beam and helical architectures, each addressing different procedural and spatial trade-offs. Molecular imaging splits into positron emission tomography and single photon systems, which have distinct tracer logistics and clinical use cases. Magnetic resonance technology is further stratified by field strength and design intent, encompassing high-field systems for conventional imaging, mid-field systems that balance performance and deployment flexibility, and ultra-low-field innovations that prioritize portability.

Ultrasound exemplifies breadth within portability, ranging from traditional two-dimensional devices to three-dimensional and Doppler-capable platforms suited for vascular and cardiology applications. The handheld segment introduces both dedicated devices and smartphone-integrated options, while wireless configurations include Bluetooth-enabled and Wi-Fi-enabled models, each with different implications for connectivity, security, and integration. X-ray follows a similar bifurcation between computed radiography and fully digital radiography approaches, emphasizing differences in image processing workflows and onsite storage requirements. Portability type further segments the market into handheld, laptop-based, and trolley-based solutions; handheld devices differentiate between dedicated hardware and smartphone-based systems, laptop-based systems may be integrated in standard or tablet forms, and trolley-based platforms present AC-operated or battery-operated variants, with corresponding implications for mobility and deployment scenarios.

Application-driven segmentation highlights the clinical contexts where portable imaging delivers the most value. Emergency use cases split into critical care and trauma workflows where rapid diagnostics are essential, while home care supports chronic disease monitoring and elderly care. Military deployments must accommodate combat zone and field hospital constraints, and point-of-care applications cover abdominal, cardiology, musculoskeletal, obstetrics, and vascular indications. Veterinary uses bifurcate into large animal and small animal modalities, each with distinct form factor and durability requirements. End-user segmentation spans clinics, diagnostic centers, home care providers, hospitals, and outpatient centers; within these categories, ownership models and institutional types-government versus private clinics, imaging centers versus laboratories, private versus public home care providers, general versus specialty hospitals, and ambulatory surgical versus rehabilitation outpatient centers-shape procurement cycles and support expectations.

Technology and price-range segmentations also play critical roles. Analog versus digital divides the market along workflow modernization lines, with film-based analog approaches giving way to cloud-enabled and on-premise digital infrastructures that alter image access and archival strategies. Price tiers-from economy low-end devices to mid-range entry and standard models and up to premium and ultra-premium high-end offerings-drive different value propositions, where high-end solutions emphasize advanced imaging capability and comprehensive service contracts, while low-end devices prioritize affordability and basic diagnostic utility. Together, these segmentation lenses provide a detailed map for vendors and buyers to assess where to focus product development, clinical validation, and commercial investment to meet nuanced customer needs.

Regional adoption patterns and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine where portable imaging gains traction

Regional dynamics play a decisive role in adoption patterns, regulatory expectations, and commercial strategies for portable diagnostic imaging. In the Americas, there is a pronounced emphasis on integration with established hospital networks, rapid adoption of point-of-care ultrasound in emergency and ambulatory settings, and a reimbursement landscape that rewards demonstrable improvements in throughput and clinical outcomes. Procurement cycles in this region often prioritize devices that can integrate seamlessly with electronic health records and enterprise imaging platforms, and vendor selection is heavily influenced by service networks and responsiveness.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks, reimbursement incentives, and capital availability vary widely. In parts of Europe, centralized procurement and strong clinical governance favor solutions with robust evidence packages and interoperability credentials. Meanwhile, Middle Eastern markets often prioritize rapid deployment capabilities and localized support, and sub-Saharan African contexts place a premium on durability, energy efficiency, and straightforward maintenance protocols. Across this combined region, opportunities exist for vendors that can offer adaptable service models and durable designs that address infrastructure variability.

Asia-Pacific exhibits dynamic demand driven by urbanization, expanding primary care capacity, and significant investments in healthcare infrastructure. Several countries in the region are advancing telemedicine and home healthcare initiatives that rely on portable imaging for remote diagnostics and chronic care management. Additionally, a growing domestic manufacturing base and evolving regulatory infrastructures influence procurement decisions, with buyers seeking scalable, cost-effective devices that can be supported across diverse geographies. These regional profiles underscore the importance of tailoring product feature sets, service offerings, and commercial approaches to local clinical practices, reimbursement environments, and infrastructure realities.

Competitive landscape dynamics where legacy manufacturing strength, focused hardware innovation, and cloud and AI partnerships converge to determine market leadership

The competitive landscape in portable diagnostic imaging is characterized by a mix of established original equipment manufacturers, specialized niche innovators, and agile startups leveraging software and AI to add diagnostic value. Established firms often compete on breadth of product portfolios, global service networks, and established regulatory pathways that facilitate large-scale procurement by health systems. These incumbents typically invest heavily in post-market surveillance, clinical studies, and comprehensive training programs to maintain trust among institutional buyers.

Concurrently, specialized firms and newer entrants are driving disruption through focused innovations in handheld ultrasound, low-field magnetic resonance systems, and compact CT designs. Their strengths lie in rapid iteration, targeted clinical validation in specific use cases, and business models oriented around software subscriptions and managed services. Partnerships between hardware developers and software or cloud providers are increasingly common, enabling devices to offer enhanced image processing, decision support, and teleconsultation capabilities. This collaboration model lowers barriers for clinical adoption by addressing interpretation bottlenecks and by enabling remote expert support.

Mergers, strategic alliances, and licensing agreements are recurrent themes, as companies seek to combine hardware competencies with advanced software capabilities and regional distribution expertise. Supply chain integration and serviceability remain competitive differentiators, particularly for buyers in decentralized care settings who prioritize uptime and local maintenance. Intellectual property in imaging reconstruction algorithms, low-power hardware designs, and AI-enabled diagnostic aids is also a critical axis of competitive advantage, with firms that can protect and commercialize these assets better positioned to capture long-term value. Overall, the company landscape rewards those who can balance product reliability with software-enabled clinical value and resilient support infrastructure.

Actionable strategic priorities for device makers and healthcare leaders to secure clinical adoption, supply resilience, and recurring revenue streams in portable imaging

Industry leaders should prioritize an integrated value proposition that pairs hardware reliability with software-enabled clinical utility and resilient post-sale support. Investing proactively in clinical evidence generation and independent validation studies will accelerate acceptance among hospital procurement committees and credentialing bodies. At the same time, modular product architectures that allow upgrades to software and connectivity features can extend device lifecycles and create recurring revenue through managed services and subscription models.

Operationally, companies should diversify supply chains and consider regional final assembly or contract manufacturing to mitigate tariff and logistics exposure. Building capacity for remote diagnostics, predictive maintenance, and spare-part forecasting will reduce downtime and strengthen customer trust, especially in decentralized care settings. Commercial strategies should emphasize partnerships with telehealth platforms, electronic health record vendors, and local service organizations to ensure seamless integration and to lower adoption friction for end users. Pricing and reimbursement strategies must be aligned with demonstrated clinical and operational benefits; value-based contracting pilots can help capture part of the efficiency gains delivered by point-of-care imaging.

Finally, investing in training programs, intuitive user interfaces, and clinician-facing decision support will broaden the addressable user base and reduce reliance on specialist operators. By combining clinical validation, software flexibility, supply chain resilience, and service excellence, industry leaders can turn current disruptions into durable competitive advantages and drive broader adoption across both institutional and non-institutional care settings.

A robust mixed-methods research approach combining primary stakeholder interviews, technical document review, and triangulated analysis to ensure actionable and validated insights

The research underpinning these insights employed a mixed-methods approach designed to triangulate primary and secondary evidence and to ensure analytical rigor. Primary research included structured interviews with clinical end users, procurement officers, and technical specialists across emergency medicine, radiology, home care, and military medical services, complemented by consultations with product managers and supply chain leaders in device manufacturing. These conversations focused on real-world performance, serviceability concerns, and adoption barriers across a range of portability formats and clinical applications.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product technical specifications, and industry whitepapers that document device performance characteristics, safety profiles, and interoperability features. Where available, authoritative standards and guidance from regulatory agencies were consulted to contextualize compliance requirements and to assess evidence expectations for clinical deployment. Data from logistics and trade publications informed analysis of supply chain patterns and tariff-related impacts, while technology trend reports helped frame developments in miniaturization, connectivity, and AI-enabled image analysis.

Analytical techniques included comparative feature mapping across segmentation lenses, scenario analysis to evaluate supply chain and tariff contingencies, and cross-validation of primary insights against documented product performance. Limitations of the methodology include variability in published clinical evidence across device classes and regional heterogeneity in procurement and reimbursement policies. To mitigate these limitations, findings were validated with multiple independent stakeholders and subjected to sensitivity checks to ensure robustness of conclusions. The resulting framework combines empirical observation with strategic interpretation to support decision-making for manufacturers, providers, and investors.

Concluding synthesis that aligns technology progress, clinical evidence, and operational resilience as the determinants of enduring success in portable imaging

Portable diagnostic imaging is at an inflection point where technological progress, changing care delivery models, and commercial innovation converge to expand diagnostic reach beyond traditional settings. Devices that marry dependable hardware with flexible software ecosystems, strong post-sale support, and clear clinical evidence will be best placed to capture the growing demand for point-of-need diagnostics. Market participants must therefore balance innovation velocity with operational excellence, ensuring that new product introductions are accompanied by service models and integration pathways that reduce adoption friction.

Regulatory, tariff, and supply chain pressures require strategic foresight, including reinforcement of sourcing strategies, investment in regional support capabilities, and transparent engagement with buyers about lifecycle costs. Clinical leaders and procurement teams should prioritize devices that demonstrate interoperability, security, and measurable impact on clinical workflows. Ultimately, the most successful solutions will be those that deliver reliable, user-friendly imaging in contexts where speed and access materially improve patient outcomes and system efficiency.

By aligning product development with validated clinical needs and by building resilient commercial and operational infrastructures, stakeholders can accelerate adoption and sustainably embed portable diagnostic imaging into diverse care pathways. The sector's momentum offers a compelling opportunity for those willing to invest in evidence, serviceability, and platform-driven value creation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for real-time analysis in portable diagnostic imaging devices
  • 5.2. Rise of handheld ultrasound devices with telemedicine connectivity for remote care and diagnostics
  • 5.3. Development of wireless battery-operated portable X-ray systems for on-site imaging in field hospitals
  • 5.4. Adoption of miniaturized computed tomography scanners for emergency and point-of-care diagnostics
  • 5.5. Expansion of cloud-based image storage and collaboration platforms for portable imaging workflows
  • 5.6. Regulatory updates accelerating approval pathways for innovative portable diagnostic imaging equipment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Portable Diagnostic Imaging Market, by Product Type

  • 8.1. CT
    • 8.1.1. Cone Beam CT
    • 8.1.2. Helical CT
  • 8.2. Molecular Imaging
    • 8.2.1. PET
    • 8.2.2. SPECT
  • 8.3. MRI
    • 8.3.1. High Field
    • 8.3.2. Mid Field
    • 8.3.3. Ultra Low Field
  • 8.4. Ultrasound
    • 8.4.1. 2D
    • 8.4.2. 3D
    • 8.4.3. Doppler
    • 8.4.4. Handheld
      • 8.4.4.1. Dedicated Device
      • 8.4.4.2. Smartphone Based
    • 8.4.5. Wireless
      • 8.4.5.1. Bluetooth Enabled
      • 8.4.5.2. Wi-Fi Enabled
  • 8.5. X-Ray
    • 8.5.1. Computed Radiography
    • 8.5.2. Digital Radiography

9. Portable Diagnostic Imaging Market, by Portability Type

  • 9.1. Handheld
    • 9.1.1. Dedicated Device
    • 9.1.2. Smartphone Based
  • 9.2. Laptop Based
    • 9.2.1. Standard Integration
    • 9.2.2. Tablet Integration
  • 9.3. Trolley Based
    • 9.3.1. AC Operated
    • 9.3.2. Battery Operated

10. Portable Diagnostic Imaging Market, by Application

  • 10.1. Emergency
    • 10.1.1. Critical Care
    • 10.1.2. Trauma
  • 10.2. Home Care
    • 10.2.1. Chronic Disease Monitoring
    • 10.2.2. Elderly Care
  • 10.3. Military
    • 10.3.1. Combat Zone
    • 10.3.2. Field Hospital
  • 10.4. Point Of Care
    • 10.4.1. Abdominal
    • 10.4.2. Cardiology
    • 10.4.3. Musculoskeletal
    • 10.4.4. Obstetrics
    • 10.4.5. Vascular
  • 10.5. Veterinary
    • 10.5.1. Large Animal
    • 10.5.2. Small Animal

11. Portable Diagnostic Imaging Market, by End User

  • 11.1. Clinics
    • 11.1.1. Government
    • 11.1.2. Private
  • 11.2. Diagnostic Centers
    • 11.2.1. Imaging Centers
    • 11.2.2. Laboratories
  • 11.3. Home Care Providers
    • 11.3.1. Private
    • 11.3.2. Public
  • 11.4. Hospitals
    • 11.4.1. General
    • 11.4.2. Specialty
  • 11.5. Outpatient Centers
    • 11.5.1. Ambulatory Surgical
    • 11.5.2. Rehabilitation

12. Portable Diagnostic Imaging Market, by Technology

  • 12.1. Analog
    • 12.1.1. Film Based
  • 12.2. Digital
    • 12.2.1. Cloud Enabled
    • 12.2.2. On Premise

13. Portable Diagnostic Imaging Market, by Price Range

  • 13.1. High End
    • 13.1.1. Premium
    • 13.1.2. Ultra Premium
  • 13.2. Low End
    • 13.2.1. Economy
  • 13.3. Mid Range
    • 13.3.1. Entry Level
    • 13.3.2. Standard

14. Portable Diagnostic Imaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Portable Diagnostic Imaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Portable Diagnostic Imaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. GE Healthcare
    • 17.3.2. Siemens Healthineers AG
    • 17.3.3. Koninklijke Philips N.V.
    • 17.3.4. Canon Medical Systems Corporation
    • 17.3.5. Fujifilm Holdings Corporation
    • 17.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.7. Samsung Medison Co., Ltd.
    • 17.3.8. Hitachi, Ltd.
    • 17.3.9. Esaote S.p.A.
    • 17.3.10. Shimadzu Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRICE RANGE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRICE RANGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PORTABLE DIAGNOSTIC IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PORTABLE DIAGNOSTIC IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PORTABLE DIAGNOSTIC IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HELICAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MOLECULAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SPECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MID FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRA LOW FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 2D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DOPPLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY X-RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMPUTED RADIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY PORTABILITY TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HANDHELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY DEDICATED DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY SMARTPHONE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY LAPTOP BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY STANDARD INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TABLET INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TROLLEY BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY EMERGENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY TRAUMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MILITARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY COMBAT ZONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY FIELD HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL PORTABLE DIAGNOSTIC IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBA